Free Trial
NASDAQ:PROC

Procaps Group (PROC) Stock Price, News & Analysis

Procaps Group logo
$0.95 -0.64 (-40.28%)
Closing price 02/3/2025
Extended Trading
$0.95 0.00 (0.00%)
As of 02/3/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Procaps Group Stock (NASDAQ:PROC)

Key Stats

Today's Range
$0.77
$1.37
50-Day Range
$0.95
$0.95
52-Week Range
$0.50
$3.78
Volume
658,169 shs
Average Volume
47,091 shs
Market Capitalization
$107.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

Receive PROC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Procaps Group and its competitors with MarketBeat's FREE daily newsletter.

PROC Stock News Headlines

Procaps Group appoints new board directors
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.
Procaps Group S.A. (PROCF)
Procaps Group Receives Delisting Notice From Nasdaq
See More Headlines

PROC Stock Analysis - Frequently Asked Questions

Procaps Group's stock was trading at $2.34 at the start of the year. Since then, PROC stock has decreased by 59.4% and is now trading at $0.95.
View the best growth stocks for 2025 here
.

Procaps Group S.A. (NASDAQ:PROC) announced its quarterly earnings results on Tuesday, December, 26th. The company reported $0.05 earnings per share for the quarter, hitting analysts' consensus estimates of $0.05. The firm had revenue of $118.41 million for the quarter, compared to analysts' expectations of $110.40 million.

Shares of PROC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Procaps Group investors own include PayPal (PYPL), Intuitive Surgical (ISRG), Adobe (ADBE), Baidu (BIDU), Cogent Communications (CCOI), Datadog (DDOG) and Illumina (ILMN).

Company Calendar

Last Earnings
12/26/2023
Today
5/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PROC
Fax
N/A
Employees
4,900
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$409.92 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
90,372,000
Market Cap
$107.18 million
Optionable
Not Optionable
Beta
-0.05
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:PROC) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners